A Reinberg1, R Manfredi, M F Kahn
1Fondation A. de Rothschild, CNRS, URA 581, Paris.
This study explored the optimal dosing time for tenoxicam, a nonsteroidal anti-inflammatory drug (NSAID), in arthritis patients. Maximum pain relief and stiffness reduction were observed when tenoxicam was administered at midday.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: